SCHEMBL6833646

SCHEMBL6833646

Cc1sc(C(=O)Nc2ccc(Br)cc2C(=O)O)cc1S(=O)(=O)Nc1ccc(F)c(Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RPA1 P27694 2/20 0.51
IDH1 O75874 5/20 0.44
GFER P55789 1/20 0.44
SIRT6 Q8N6T7 1/20 0.43
MAPT P10636 2/20 0.43
METAP2 P50579 2/20 0.43
TP53 P04637 1/20 0.43
FABP4 P15090 2/20 0.42
FABP5 Q01469 2/20 0.42
AKR1C2 P52895 1/20 0.41
AKR1C1 Q04828 1/20 0.41
SLC10A2 Q12908 1/20 0.41
SLC10A1 Q14973 1/20 0.41
SLC10A6 Q3KNW5 1/20 0.41
THRB P10828 1/20 0.41
HPGD P15428 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
PTGES O14684 1/20 0.40
ALOX5 P09917 1/20 0.40
FABP3 P05413 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6833867 0.90 METAP2 (0.52) RPA1IDH1GFERMAPTMETAP2
SCHEMBL6818512 0.84 RPA1 (0.51) RPA1IDH1GFERSIRT6MAPT
SCHEMBL6360706 0.83 RPA1 (0.50) RPA1IDH1GFERSIRT6MAPT
SCHEMBL6833850 0.82 RAB9A (0.45) RPA1IDH1GFERMAPTHPGD
SCHEMBL6835657 0.82 LMNA (0.48) RPA1GFERMETAP2TP53SMN1; SMN2
SCHEMBL6347755 0.78 MIF (0.54) RPA1MAPTMETAP2TP53AKR1C2
SCHEMBL6833981 0.77 RPA1 (0.43) RPA1GFERMAPTMETAP2TP53
SCHEMBL6835788 0.76 METAP2 (0.45) IDH1MAPTMETAP2AKR1C2AKR1C1
SCHEMBL6834271 0.74 MEN1 (0.49) MAPTMETAP2TP53THRBHPGD
SCHEMBL6834061 0.74 POLB (0.46) METAP2AKR1C2AKR1C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040110802-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040110802-A1 Antibacterial benzoic acid derivatives GABRD, GABBR1, GABRA1 RPA1 3767/4885IDH1 4018/4885GFER 900/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.